NeuroOne Medical Technologies Corporation
$4.98
▼
-0.87%
2026-04-21 08:26:00
nmtc1.com
NCM: NMTC
Explore NeuroOne Medical Technologies Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$40.89 M
Current Price
$4.98
52W High / Low
$6.96 / $3
Stock P/E
—
Book Value
$0.13
Dividend Yield
—
ROCE
-49.83%
ROE
-1.46%
Face Value
—
EPS
$-0.18
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
18
Beta
0.58
Debt / Equity
3.71
Current Ratio
6.41
Quick Ratio
3.47
Forward P/E
-2.61
Price / Sales
3.17
Enterprise Value
$33.65 M
EV / EBITDA
-4.56
EV / Revenue
2.87
Rating
None
Target Price
$2.03
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | NeuroPace, Inc. | $16.53 | — | $545.07 M | — | -18.62% | -1.59% | $18.98 / $7.56 | $0.57 |
| 2. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 3. | Modular Medical, Inc. | $5.41 | — | $27.31 M | — | -109.03% | -3.32% | $34.5 / $3.55 | $2.27 |
| 4. | Butterfly Network, Inc. | $5.49 | — | $1.39 B | — | -37.34% | -42.25% | $5.62 / $1.32 | $0.77 |
| 5. | Integra LifeSciences Holdings Corporation | $11.16 | — | $875.54 M | — | 0.57% | -39.9% | $17.54 / $8.7 | $13.4 |
| 6. | Enovis Corporation | $26.27 | — | $1.52 B | — | -0.58% | -58.27% | $37.85 / $21 | $26.05 |
| 7. | Nexalin Technology, Inc. | $0.47 | — | $9.54 M | — | -223.88% | -2.22% | $2 / $0.33 | $0.2 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 2.89 M | 2.74 M | 1.7 M | 1.39 M | 3.27 M |
| Operating Profit | -1.71 M | -1.37 M | -1.89 M | -2.68 M | 1.71 M |
| Net Profit | -1.44 M | -1.62 M | -1.5 M | -2.27 M | 1.79 M |
| EPS in Rs | -0.03 | -0.03 | -0.03 | -0.04 | 0.04 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 9.1 M | 3.45 M | 1.95 M | 0.17 M |
| Operating Profit | -4.23 M | -11.89 M | -11.96 M | -10.03 M |
| Net Profit | -3.61 M | -12.32 M | -11.86 M | -10 M |
| EPS in Rs | -0.07 | -0.24 | -0.23 | -0.2 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 10.79 M | 5.37 M | 8.1 M | 12.82 M |
| Total Liabilities | 3.71 M | 4.55 M | 1.85 M | 3.22 M |
| Equity | 7.07 M | 0.82 M | 6.25 M | 9.6 M |
| Current Assets | 10.23 M | 4.63 M | 7.31 M | 12.18 M |
| Current Liabilities | 2.3 M | 2.21 M | 1.79 M | 3.1 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -2.84 M | -11.01 M | -12.89 M | -7.52 M |
| Investing CF | -0.08 M | -0.12 M | 2.65 M | -3.24 M |
| Financing CF | 8.03 M | 7.27 M | 7.4 M | 12.02 M |
| Free CF | -2.92 M | -11.13 M | -13.27 M | -7.79 M |
| Capex | -0.08 M | -0.12 M | -0.38 M | -0.28 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 76.86% | 1040.65% | — | — |
| Earnings Growth % | -3.87% | -18.6% | — | — |
| Profit Margin % | -356.74% | -607.42% | -5841.95% | — |
| Operating Margin % | -344.26% | -612.32% | -5860.15% | — |
| Gross Margin % | 31.27% | 23.38% | -41.36% | — |
| EBITDA Margin % | -342.96% | -597.21% | -5790.85% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.